
    
      RhuDex® is a novel, orally bioavailable, low molecular weight modulator of co-stimulation of
      T lymphocytes. RhuDex® binds to the protein CD80 on the surface of antigen-presenting cells
      and inhibits its interaction with CD28 (but not with CTLA-4) presented by CD4+ T lymphocytes.
    
  